- Home
- BDX
as 12-20-2024 4:00pm EST
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2024 revenue) and BD Interventional (24%) account for the remainder. International revenue accounts for 43% of the company's business.
| Founded: | 1897 | Country: | United States |
| Employees: | N/A | City: | FRANKLIN LAKES |
| Market Cap: | 65.8B | IPO Year: | 1962 |
| Target Price: | $283.50 | AVG Volume (30 days): | 2.4M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 6 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 5.86 | EPS Growth: | 18.61 |
| 52 Week Low/High: | $218.75 - $249.89 | Next Earning Date: | 02-06-2025 |
| Revenue: | $20,178,000,000 | Revenue Growth: | 4.16% |
| Revenue Growth (this year): | 10.16% | Revenue Growth (next year): | 5.05% |
Stock Insider Trading Activity of Becton Dickinson and Company (BDX)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Neal Shana Carol | BDX | EVP and Chief People Officer | Dec 6 '24 | Sell | $220.49 | 1,000 | $220,490.00 | 16,989 | |
| Goette Roland | BDX | EVP and President, EMEA | Dec 6 '24 | Sell | $220.02 | 5,121 | $1,130,528.97 | 24,345 | |
| Shan David | BDX | EVP and Chief ISC Officer | Dec 5 '24 | Sell | $220.25 | 1,500 | $330,375.00 | 6,285 |
Latest Becton Dickinson and Company News
BDX Breaking Stock News: Dive into BDX Ticker-Specific Updates for Smart Investing
MT Newswires
2 days ago
Becton Dickinson & Co Insider Sold Shares Worth $633,811, According to a Recent SEC Filing
Zacks
2 days ago
Why Becton Dickinson (BDX) is a Top Growth Stock for the Long-Term
Zacks
4 days ago
BDX Stock Down Despite New Expansion to Boost Fingertip Blood Testing
Zacks
4 days ago
Here's Why Becton Dickinson (BDX) is a Strong Value Stock
Medical Device Network
4 days ago
BD and Babson expand fingertip blood testing across US health systems
Zacks
5 days ago
Why Becton Dickinson (BDX) is a Top Momentum Stock for the Long-Term
PR Newswire
5 days ago
BD and Babson Diagnostics Launch Innovative Fingertip Blood Testing to Health Care Organizations
Bloomberg
5 days ago
Becton Dickinson to Pay $175 Million to Settle SEC Probe
Compare BDX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BDX Becton Dickinson and Company - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.